GDF15 and chronic kidney disease: Consequently, in CKD-associated hypertension, GDF-15 may exert its influence through multiple pathways, which encompass not only the regulatory mechanisms activated by renal impairment but also potential pharmacological mechanisms involving receptor desensitization and saturation.